Melvyn I Marquis
Examiner (ID: 16161)
Most Active Art Unit | 1501 |
Art Unit(s) | 1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401 |
Total Applications | 2620 |
Issued Applications | 2300 |
Pending Applications | 26 |
Abandoned Applications | 294 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13314903
[patent_doc_number] => 20180208988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS OF DIAGNOSIS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/921160
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15921160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/921160 | METHODS OF DIAGNOSIS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE | Mar 13, 2018 | Abandoned |
Array
(
[id] => 16484330
[patent_doc_number] => 20200377931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => DNA CHIP FOR DETECTING DENTAL CARIES BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/493082
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493082
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493082 | DNA chip for detecting dental caries bacteria | Mar 12, 2018 | Issued |
Array
(
[id] => 19043822
[patent_doc_number] => 11932909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Methylation classifier for detection of HPV-induced invasive cancers, nonHPV-induced gynaecological and anogenital cancers and their high-grade precursor lesions
[patent_app_type] => utility
[patent_app_number] => 16/491182
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9961
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491182
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491182 | Methylation classifier for detection of HPV-induced invasive cancers, nonHPV-induced gynaecological and anogenital cancers and their high-grade precursor lesions | Mar 8, 2018 | Issued |
Array
(
[id] => 15949169
[patent_doc_number] => 10662476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
[patent_app_type] => utility
[patent_app_number] => 15/915581
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 36035
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915581 | Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support | Mar 7, 2018 | Issued |
Array
(
[id] => 13552535
[patent_doc_number] => 20180327815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => METHODS OF DETECTING AND TYPING PATHOGENIC STRAINS OF FRANCISELLA TULARENSIS
[patent_app_type] => utility
[patent_app_number] => 15/908808
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15908808
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/908808 | METHODS OF DETECTING AND TYPING PATHOGENIC STRAINS OF FRANCISELLA TULARENSIS | Feb 27, 2018 | Abandoned |
Array
(
[id] => 14551757
[patent_doc_number] => 10344323
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-07-09
[patent_title] => CPG sites differentially methylated in smokers and non-smokers
[patent_app_type] => utility
[patent_app_number] => 15/900321
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 11755
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900321 | CPG sites differentially methylated in smokers and non-smokers | Feb 19, 2018 | Issued |
Array
(
[id] => 15619485
[patent_doc_number] => 20200080147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => METHODS AND COMPOSITIONS FOR TUMOR ASSESSMENT
[patent_app_type] => utility
[patent_app_number] => 16/485160
[patent_app_country] => US
[patent_app_date] => 2018-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485160
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485160 | METHODS AND COMPOSITIONS FOR TUMOR ASSESSMENT | Feb 17, 2018 | Abandoned |
Array
(
[id] => 12863269
[patent_doc_number] => 20180179597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => CANCER MARKERS
[patent_app_type] => utility
[patent_app_number] => 15/896811
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15896811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/896811 | CANCER MARKERS | Feb 13, 2018 | Abandoned |
Array
(
[id] => 15180867
[patent_doc_number] => 20190361025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => LIQUID BIOPSIES FOR DETECTION OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/484791
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484791 | LIQUID BIOPSIES FOR DETECTION OF PROSTATE CANCER | Feb 8, 2018 | Pending |
Array
(
[id] => 12886267
[patent_doc_number] => 20180187264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => MARKERS TO PREDICT MACROCYCLIC LACTONE DRUG RESISTANCE IN DIROFILARIA IMMITIS, THE CAUSATIVE AGENT OF HEARTWORM DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/887164
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887164
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887164 | Markers to predict macrocyclic lactone drug resistance in | Feb 1, 2018 | Issued |
Array
(
[id] => 15117865
[patent_doc_number] => 20190345565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => METHOD FOR INDICATING A PRESENCE OR NON-PRESENCE OF PROSTATE CANCER IN INDIVIDUALS WITH PARTICULAR CHARACTERISTICS
[patent_app_type] => utility
[patent_app_number] => 16/481956
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481956 | METHOD FOR INDICATING A PRESENCE OR NON-PRESENCE OF PROSTATE CANCER IN INDIVIDUALS WITH PARTICULAR CHARACTERISTICS | Jan 31, 2018 | Pending |
Array
(
[id] => 13343681
[patent_doc_number] => 20180223380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => PROBE COMBINATION FOR DETECTION OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/885717
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15885717
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/885717 | Probe combination for detection of cancer | Jan 30, 2018 | Issued |
Array
(
[id] => 12837526
[patent_doc_number] => 20180171015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => Method of Increasing GIPCR Signalization in the Cells of a Scoliotic Subject
[patent_app_type] => utility
[patent_app_number] => 15/878538
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878538
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878538 | Method of Increasing GIPCR Signalization in the Cells of a Scoliotic Subject | Jan 23, 2018 | Abandoned |
Array
(
[id] => 15711703
[patent_doc_number] => 20200102617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Improved Methods For Assessing Risk of Developing Breast Cancer
[patent_app_type] => utility
[patent_app_number] => 16/480516
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480516
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480516 | Improved Methods For Assessing Risk of Developing Breast Cancer | Jan 22, 2018 | Abandoned |
Array
(
[id] => 12908863
[patent_doc_number] => 20180194796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => TRACEABLE NUCLEIC ACID MARKED FERTILIZER
[patent_app_type] => utility
[patent_app_number] => 15/870035
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870035
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870035 | TRACEABLE NUCLEIC ACID MARKED FERTILIZER | Jan 11, 2018 | Abandoned |
Array
(
[id] => 13314863
[patent_doc_number] => 20180208968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS FOR DEPLETING RNA FROM NUCLEIC ACID SAMPLES
[patent_app_type] => utility
[patent_app_number] => 15/866840
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866840
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/866840 | Methods for depleting RNA from nucleic acid samples | Jan 9, 2018 | Issued |
Array
(
[id] => 15117861
[patent_doc_number] => 20190345563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => EX-VIVO METHOD FOR THE PROGNOSIS OF METASTASIS IN PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/474459
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3629
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474459
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474459 | EX-VIVO METHOD FOR THE PROGNOSIS OF METASTASIS IN PROSTATE CANCER | Dec 28, 2017 | Pending |
Array
(
[id] => 12886261
[patent_doc_number] => 20180187262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/858282
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858282
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/858282 | METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE | Dec 28, 2017 | Abandoned |
Array
(
[id] => 14567541
[patent_doc_number] => 20190211377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => COBRA PROBES TO DETECT A MARKER FOR EPIDEMIC RIBOTYPES OF CLOSTRIDIUM DIFFICILE
[patent_app_type] => utility
[patent_app_number] => 15/845097
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15845097
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/845097 | COBRA PROBES TO DETECT A MARKER FOR EPIDEMIC RIBOTYPES OF CLOSTRIDIUM DIFFICILE | Dec 17, 2017 | Abandoned |
Array
(
[id] => 15150375
[patent_doc_number] => 20190353665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => METHOD FOR DIAGNOSING A SKIN DISPLAYING SIGNS OF DRYNESS
[patent_app_type] => utility
[patent_app_number] => 16/466460
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/466460 | METHOD FOR DIAGNOSING A SKIN DISPLAYING SIGNS OF DRYNESS | Dec 13, 2017 | Pending |